As previously reported, Guggenheim downgraded Acadia Pharmaceuticals (ACAD) to Neutral from Buy with a price target of $20, down from $23. The ...

When prices go up, there usually isn’t a huge reaction because the people who go to museums value what they get there very ...

Big Lots, Inc. (the "Company") today announced that it has successfully closed its previously announced sale agreement with ...

Guggenheim named MSG Entertainment (MSGE) as a best idea entering 2025. Shares have slid about 23% since fiscal Q1 earnings ...

Guggenheim Active Allocation Fund (NYSE:GUG – Get Free Report) shares fell 0.5% during trading on Wednesday . The company traded as low as $14.78 and last traded at $14.87. 191,595 shares changed ...

Guggenheim analyst Yatin Suneja downgraded Acadia Pharmaceuticals (ACAD) to Neutral from Buy with a $20 price target Published first on TheFly – ...

At the closing bell on Friday, the blue chip Dow Jones Industrial Average was up 0.8% to 42,732, the broader S&P 500 added ...

With its stunning Frank Lloyd Wright design, the Guggenheim Museum is a piece of art in itself. Inside these rounded walls, ...

Altimmune Inc (ALT) stock saw a decline, ending the day at $7.11 which represents a decrease of $-0.10 or -1.39% from the prior close of $7.21. The stock opened at $7.31 and touched a low of $6.95 ...

Guggenheim initiates Reddit with a buy rating, forecasting significant growth and a price target of $210, implying over 28% ...

Michael Morris, Guggenheim Securities analyst, joins 'Squawk on the Street' to discuss what's at stake for Netflix, some of ...

Vistra leads surge in nuclear power plant operators, outperforming tech sector with record gains and analyst predictions for ...